Brill Daniel, Papaliodis George
Ocular Immunology and Uveitis Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
Semin Ophthalmol. 2021 May 19;36(4):296-303. doi: 10.1080/08820538.2021.1896753. Epub 2021 Mar 23.
Spurred by the coronavirus disease pandemic and shortage of eye care providers, telemedicine is transforming the way ophthalmologists care for their patients. Video conferencing, ophthalmic imaging, hybrid visits, intraocular inflammation quantification, and portable technology are evolving areas that may allow more uveitis patients to be evaluated via telemedicine. Despite these promising disruptive technologies, there remain significant technological limitations, legal barriers, variable insurance coverage for virtual visits, and lack of clinical trials for uveitis specialists to embrace telemedicine.
在冠状病毒病大流行和眼科护理人员短缺的推动下，远程医疗正在改变眼科医生照顾患者的方式。视频会议、眼科成像、混合就诊、眼内炎症量化和便携式技术是不断发展的领域，可能使更多葡萄膜炎患者能够通过远程医疗进行评估。尽管有这些前景广阔的颠覆性技术，但仍然存在重大的技术限制、法律障碍、虚拟就诊的保险覆盖范围不一，以及缺乏供葡萄膜炎专家采用远程医疗的临床试验。
